Cornerstone Pharmaceuticals Commences Phase I Clinical Trial of CPI-613 for the Treatment of B-Cell Non-Hodgkin Lymphoma

Source: Medical News (via PRIMEZONE) - Category: Pharmaceuticals Source Type: news